T1	p 47 67	the premature monkey
T2	p 196 276	premature monkey ( Macaca nemestrina ) model of hyaline membrane disease ( HMD )
T3	p 279 290	Twelve dams
T4	p 406 428	Twelve control animals
T5	i 91 104	dexamethasone
T6	i 147 161	glucocorticoid
T7	i 300 313	dexamethasone
T8	i 438 444	saline
T9	i 458 479	dexamethasone-treated
T10	i 805 826	dexamethasone-treated
T11	i 1040 1061	dexamethasone-treated
T12	i 1512 1525	dexamethasone
T13	i 1633 1646	dexamethasone
T14	o 509 538	incidence and severity of HMD
T15	o 707 731	volume-pressure behavior
T16	o 770 784	distensibility
T17	o 915 934	deflation stability
T18	o 964 1023	production of surface active material ( SAM ) phospholipids
T19	o 1097 1120	total lung phospholipid
T20	o 1194 1228	alveolar lavage fluid phospholipid
T21	o 1307 1360	alveolar lavage fluid disaturated phosphatidylcholine
T22	o 1460 1473	14C-palmitate
T23	o 1479 1489	lung lipid
T24	o 1688 1730	incidence and severity of experimental HMD
T25	o 1837 1862	fetal pulmonary functions